Galena Biopharma, Inc. (GALE) has 17 open-market insider trades by 10 insiders since 2011. The most active filer is Rudolph Nisi, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Sander Gerber | 10% Owner | — | 1 | $4.0M | 2017-02-08 |
| Mark J. Ahn | Pres | — | 2 | $3.9M | 2014-06-30 |
| Steven A. Kriegsman | Dir | — | 2 | $3.8M | 2014-01-23 |
| Rudolph Nisi | Dir | — | 4 | $2.8M | 2017-10-10 |
| Sanford Hillsberg | Dir | — | 2 | $2.7M | 2017-10-10 |
| Stephen S. Galliker | Dir | — | 1 | $1.3M | 2017-10-10 |
| Richard Chin | Dir | — | 2 | $1.2M | 2017-10-10 |
| Mark W. Schwartz | Pres | — | 1 | $557K | 2016-07-01 |
| Ryan Dunlap | CFO | — | 1 | $553K | 2016-06-01 |
| Kwang Lee | Principal Accounting Officer | — | 1 | $3K | 2011-12-07 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Rudolph Nisi | Director | Sell | $275 | 2017-06-20 |
| Sander Gerber | 10% Owner | Sell | $4.0M | 2017-02-08 |
| Ryan Dunlap | CFO | Sell | $553K | 2016-06-01 |
| Richard Chin | Director | Sell | $812K | 2014-02-12 |
| Rudolph Nisi | Director | Buy | $99K | 2014-02-07 |
| Stephen S. Galliker | Director | Sell | $1.3M | 2014-02-03 |
Companies that share insiders with GALE, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Sanford Hillsberg | Director | Sell | $1.4M | 2014-01-30 |
| Richard Chin | Director | Sell | $419K | 2014-01-30 |
| Mark W. Schwartz | COO | Sell | $557K | 2014-01-30 |
| Rudolph Nisi | Director | Sell | $1.3M | 2014-01-29 |
| Mark J. Ahn | President | Sell | $3.8M | 2014-01-27 |
| Steven A. Kriegsman | Director | Sell | $888K | 2014-01-23 |
| Sanford Hillsberg | Director | Sell | $1.4M | 2014-01-17 |
| Steven A. Kriegsman | Director | Sell | $2.9M | 2014-01-17 |
| Rudolph Nisi | Director | Sell | $1.4M | 2014-01-17 |